J. Leuven, C. Kluft, M. Dersjant-Roorda, E. Harthoorn‐Lasthuizen, R. D. Boer, F.M. Helmerborst
{"title":"不同孕激素组合的低剂量炔雌醇口服避孕药对静脉和动脉血栓栓塞性疾病凝血和纤溶危险变量的影响","authors":"J. Leuven, C. Kluft, M. Dersjant-Roorda, E. Harthoorn‐Lasthuizen, R. D. Boer, F.M. Helmerborst","doi":"10.1201/9780367812829-32","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":110007,"journal":{"name":"Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis","volume":"282 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Low-Dose Ethinylestradiol Oral Contraceptives Differing in Progestogen Compound on Coagulation- and Fibrinolytic-Risk Variables for Venous and Arterial Thromboembolic Diseases\",\"authors\":\"J. Leuven, C. Kluft, M. Dersjant-Roorda, E. Harthoorn‐Lasthuizen, R. D. Boer, F.M. Helmerborst\",\"doi\":\"10.1201/9780367812829-32\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":110007,\"journal\":{\"name\":\"Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis\",\"volume\":\"282 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1201/9780367812829-32\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fibrinolysis in Disease Molecular and Hemovascular Aspects of Fibrinolysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/9780367812829-32","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effects of Low-Dose Ethinylestradiol Oral Contraceptives Differing in Progestogen Compound on Coagulation- and Fibrinolytic-Risk Variables for Venous and Arterial Thromboembolic Diseases